glutathione parkinsons disease Ferroptosis in Parkinson's disease: glia–neuron crosstalk Glutathione S-transferase: A keystone in
Description
(3) Technical limitations: polymeric nanocarriers suffer from premature drug leakage
doi: 10.1001/jamanetworkopen.2024.60283 9
Medicine 96 , e5887 (2017)
As shown in Table 3, a total of 66 Phase III/IV clinical trials were selected based on the aforementioned criteria
Contribution to Drug Clearance : Both Phase I and Phase II metabolism play important roles in the overall clearance of drugs and xenobiotics from the body
2017;13(3): e1006249
